Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Japanese Journal of Cancer Research : Gann|December 21, 2000
Cytotoxicity of cis-[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(myristato)]-platinum (II) suspended in Lipiodol in a newly established cisplatin-resistant rat hepatoma cell lineS Kishimoto, K Miyazawa, Y Terakawa, et al.No Shinkei Geka. Neurological Surgery|October 30, 2001
[Management strategies for unruptured cerebral aneurysms]T Murata, T Tsuruno, K Shimotake, et al.Acta Neurochirurgica|January 24, 2004
Development of malignant glioma 15 months after anterior temporal lobectomy in a patient with temporal lobe epilepsyM Morino, T Ichinose, Y Terakawa, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|June 24, 2008
Quantitative analysis of MEG using modified sLORETA for clinical applicationY Terakawa, N Tsuyuguchi, H Tanaka, et al.Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences|July 2, 2010
Spinal arteriovenous malformation associated with a radicular arteriovenous fistula suggested a metameric disease. A case reportA Nishio, K Ohata, T Takami, et al.Biochemical and Biophysical Research Communications|December 15, 1992
A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II)M Masuda, H Nakashima, T Ueda, et al.Journal of Medicinal Chemistry|March 26, 1999
Novel, potent, and selective phosphodiesterase-4 inhibitors as antiasthmatic agents: synthesis and biological activities of a series of 1-pyridylnaphthalene derivativesT Ukita, M Sugahara, Y Terakawa, et al.Chemical & Pharmaceutical Bulletin|January 1, 1995
Solution-phase synthesis of an anti-human immunodeficiency virus peptide, T22 ([Tyr5,12,Lys7]-polyphemusin II), and the modification of Trp by the p-methoxybenzyl group of Cys during trimethylsilyl trifluoromethanesulfonate deprotectionH Tamamura, A Otaka, W Takada, et al.Biological & Pharmaceutical Bulletin|December 1, 1994
Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II)A Otaka, H Tamamura, Y Terakawa, et al.Pageof 1